Homocysteineinduced oxidative stress through TLR4/NFκB/DNMT1mediated LOX1 DNA methylation in endothelial cells

Sheng-Chao Ma1, Yin-Ju Hao1, Yun Jiao2

  • 1School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.

Insights

Elevated homocysteine (Hcy) injures endothelial cells by altering LOX-1 DNA methylation via the TLR4/NF-κB/DNMT1 pathway, contributing to atherosclerosis development.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Cellular Pathology

Background:

  • Atherosclerosis (AS) is a complex, progressive disease initiated by endothelial injury.
  • Elevated homocysteine (Hcy) is implicated in endothelial dysfunction and oxidative stress, but mechanisms are unclear.
  • Lectin-like oxidized-low density lipoprotein receptor-1 (LOX-1) plays a role in endothelial response to injury.

Purpose of the Study:

  • To investigate if Hcy induces endothelial cell (EC) injury via LOX-1 DNA methylation.
  • To elucidate the role of the toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB/DNA methyltransferase (DNMT)1 pathway in Hcy-induced EC damage.
  • To explore the association between Hcy, oxidative stress, and LOX-1 expression in ECs.

Main Methods:

  • Endothelial cells were treated with varying concentrations of Hcy.
  • Oxidative stress markers (superoxide dismutase, malondialdehyde, hydrogen peroxide) were measured.
  • The effect of pyrrolidine dithiocarbamate (PDTC) on NF-κB and DNMT1 was assessed.

Main Results:

  • Hcy promoted TLR4 expression, leading to EC injury.
  • Hcy induced LOX-1 DNA hypomethylation, increasing LOX-1 expression.
  • Hcy-induced EC injury involved methylation and trans-sulfuration metabolism of LOX-1 through the TLR4/NF-κB/DNMT1 pathway.

Conclusions:

  • Hcy injures endothelial cells by modulating LOX-1 DNA methylation via the TLR4/NF-κB/DNMT1 signaling cascade.
  • This Hcy-induced endothelial injury facilitates lipid accumulation, promoting atherosclerosis progression.
  • Understanding these mechanisms offers potential therapeutic targets for atherosclerosis.